Tabuk Pharmaceuticals to manufacture four Pfizer products
30/06/2014 5:57 am EDT

share with your network:

Saudi-based Tabuk Pharmaceuticals has said it has signed a commercial agreement with Pfizer, the US-based global industry leader, Arab News has reported. The deal aims to deliver increased value to patients in the cardiovascular, central nervous system, anti-infective and respiratory therapeutic areas. Under the agreement, Pfizer will grant Tabuk exclusive rights to carry out manufacturing processes under licence, commercialise and distribute second brand versions of four Pfizer products in the kingdom.

About the Author

share with your network:

Share your view

© 1996-2016 Media quest FZ LLC A media and entertainment company
Middle East Main Office
[email protected]
© 2016 Dubai Business | Ameinfo . All rights Reserved.